SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-046883
Filing Date
2024-04-23
Accepted
2024-04-23 16:05:25
Documents
19
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A rlay-20240422.htm   iXBRL DEF 14A 2068003
2 GRAPHIC img68939711_0.jpg GRAPHIC 164524
3 GRAPHIC img68939711_1.jpg GRAPHIC 164524
4 GRAPHIC img68939711_2.jpg GRAPHIC 665345
5 GRAPHIC img68939711_3.jpg GRAPHIC 540995
6 GRAPHIC img68939711_4.jpg GRAPHIC 530500
7 GRAPHIC img68939711_5.jpg GRAPHIC 389947
8 GRAPHIC img68939711_6.jpg GRAPHIC 917778
9 GRAPHIC img68939711_7.jpg GRAPHIC 565304
  Complete submission text file 0000950170-24-046883.txt   13147566

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rlay-20240422.xsd EX-101.SCH 57283
22 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20240422_htm.xml XML 543370
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39385 | Film No.: 24864829
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)